Drug Trial Radar · NCT01555164
A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone
Last checked: Nov 20, 2026Latest source record: Sep 23, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
442
Actual
Start
Jun 2012
Primary completion
Sep 2013
Study completion Oct 2013
Sponsor
- Lead sponsor
- Gilead SciencesGilead Sciences (GILD)
- Sponsor type
- Industry
- First posted
- Mar 15, 2012
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, double-blind, placebo-controlled, parallel-group, multicenter study to determine the effect of ranolazine when added to metformin on glycemic control in adults with type 2 diabetes mellitus (T2DM) who are inadequately controlled despite current treatment with stable metformin therapy in addition to diet and exercise.
Conditions
- Type 2 Diabetes Mellitus
Interventions
RanolazineDrug
Ranolazine tablet(s) administered orally
Placebo to match ranolazineDrug
Placebo to match ranolazine for the duration of the study
MetforminDrug
Metformin tablet(s) administered orally once daily
Placebo to match metforminDrug
Placebo to match metformin for the duration of the study
DietBehavioral
Participants are instructed to continue the diet regimen prescribed by their physician.
ExerciseBehavioral
Participants are instructed to continue the exercise regimen prescribed by their physician.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Week 24Time frame: Baseline; Week 24
Locations
146 sites in 11 countries. Site status is shown where the registry gives one.
Fundamental Research LLC
Gulf Shores, Alabama
KLR Business Group DBA Arkansas Clinical Research
Little Rock, Alaska
Radiant Research, Inc.
Chandler, Arizona
Central Phoenix Medical Clinic
Phoenix, Arizona
Clinical Research Advantage
Tempe, Arizona
Desert Sun Clinical Research, LLC
Tucson, Arizona
National Research Institute
Los Angeles, California
Ritchken and First MD's
San Diego, California
Clearview Medical Research, LLC
Santa Clarita, California
Metabolic Institute of America
Tarzana, California
University Clinical Investigators
Tustin, California
Infosphere Clinical Research
West Hills, California
Colorado Springs Health Partners
Colorado Springs, Colorado
Boca Raton Clinical Research Associates, Inc.
Boca Raton, Florida
MD Clinical Institute
Hallandale, Florida
A G A Clinical Trials
Hialeah, Florida
Baptist Diabetes Associates
Miami, Florida
Florida Institute for Clinical Research LLC
Orlando, Florida
Medical Research Group of Central Florida
Sanford, Florida
Synergy Therapeutic Partners
Atlanta, Georgia
Perimeter Institute for Clinical Research
Atlanta, Georgia
Columbus Research Foundation
Columbus, Georgia
Advanced Clinical Research
Boise, Idaho
Choose To Lose
Eagle, Idaho
Cedar-Crosse Research Center
Chicago, Illinois
Alexandria Cardiology Clinic
Alexandria, Louisiana
Covington Medical Care
Mandeville, Louisiana
Clinical Trials Management, LLC
Metairie, Louisiana
MD Medical Research
Oxon Hill, Maryland
Bellevue Family Practice
Bellevue, Nebraska
Clinical Research Advantage
Henderson, Nevada
Albuquerque Clinical Trials, Inc.
Albuquerque, New Mexico
University of New Mexico Health Sciences Center
Albuquerque, New Mexico
PhysiqueMed Clinical Trials
Greensboro, North Carolina
Clinical Trials of America Inc
Hickory, North Carolina
University Medical Associates
Huntersville, North Carolina
Northstate Clinical Research
Lenoir, North Carolina
Carolina Research Center
Shelby, North Carolina
Lillestol Research
Fargo, North Dakota
Rapid Medical Research, Inc
Cleveland, Ohio
Showing 40 of 146 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.